Blood test could predict risk of 67 diseases
Confirms my view that screening is the key to faster diagnosis of Myeloma and other cancers/diseases. See @iStopMM study. NOT ‘raising awareness’ or GP education.
thetimes.com/article/cfea76b…
Bob Munro retweeted
Here is a blog I wrote about why I feel MRD negativity should be used as a surrogate endpoint in #myeloma clinical trials. MRD as a Clinical Trial Endpoint: A Patient Perspective healthtree.org/myeloma/commu… #MMSM
Bob Munro retweeted
Summary of drug approvals in relapsed myeloma. 19 new drugs approved over 20 years.
Bookmark it! #MedTwitter
#worldcancerday earlier diagnosis leads to better outcomes @MyelomaUK @TheBindingSite @ITNProductions linkedin.com/posts/activity-…
4
118
Bob Munro retweeted
‘Shaping the Future of Cancer Care', Bob Munro @MyeCyclist, @MyelomaUK patient advocate discusses his myeloma journey and Dr Ross Sadler covers the importance of primary care providers.
Available, 9am on #WorldCancerDay, Sunday 4th February: business.itn.co.uk/programme… #cancercare
I'm fundraising for Myeloma UK. Check out my @JustGiving page and please donate if you can. Thank you! #JustGiving justgiving.com/fundraising/l…
4
97
My 1st Complete Remission after 11 years of continuous treatment. A minor miracle!! Help me, help other Myeloma patients with more new drugs and to find a cure. Read my story #Cycling4Cure #MyelomaUK. Check out my @JustGiving please donate #JustGiving justgiving.com/fundraising/l…
Bob Munro retweeted
Please retweet and help us reach over 1000 respondents so we can get a representation of everyone's experiences. If you are/have been affected by myeloma/related conditions (e.g MGUS, smouldering myeloma) we want to hear from you! Survey 2 closes at midnight on Sunday.
🧵1/4 Thank you to all of the amazing patients and carers who have taken part in Survey 2 of our Unmet and Emerging Needs research so far.
There's still time to take the survey and share your experiences with us: opinions.research-interactiv…
Bob Munro retweeted
Only a week until our Unmet and Emerging Needs Survey closes! If you can, please fill it in and tell us more about your experiences. Please also reshare to help us reach as many people as possible. 🧡
We were delighted by the response to our first Unmet and Emerging Needs Survey, with over 1,000 of you taking part! Please fill in our final Unmet and Emerging Needs Survey and tell us more about your experiences: opinions.research-interactiv…
Bob Munro retweeted
Cancer continues to threaten millions of lives
But to witness a stage IV patient enter remission, having received not a drop of chemotherapy but rather immunotherapy, is a near-miracle I didn’t foresee when my career began
Not all tears in an oncology clinic are shed in sadness
Bob Munro retweeted
🧵 1/3 We're delighted to announce the appointment of Professor Graham Jackson as Myeloma UK's first Chief Clinical and Scientific Advisor! @profghjackson
myeloma.org.uk/news/myeloma-…
Bob Munro retweeted
Real world data from Canada for transplant eligible patients with myeloma shows median overall survival of 10 years:
13 years for std risk
7.5 years for high risk.
This is real progress. #ASH22 #JulieCote @HiraSMian ash.confex.com/ash/2022/webp…
Great summary of really encouraging Myeloma treatment developments, particularly Car-T and Bi-Specifics. After 10 years of continuous treatment, I am currently on a Bi-Specific trial (Teclistamab) leaving me within a whisker of my first ever remission @MyMKaiser @MyelomaUK
I just attended one of the biggest cancer meetings in the world. #ASH22 @ASH_hematology
For my followers here is a snapshot of the incredible progress happening with cancer treatment. It’s good. Thread.
Fantastic to see @MyMKaiser helping to save/improve the lives of so many myeloma patients in addition to mine 😍
A full house for @MyMKaiser at #ASH2022 presenting the exciting results of Optimum/MUK9. Early screening for ultra high risk myeloma is feasible within the NHS, and good outcomes can be achieved with intensive and extended treatment. @MyelomaUK involved in trial design.
Bob Munro retweeted
Great to hear results showing performance and potential of BiSpecifics - #HopefulFuture room filled ... overflow rooms needed to accommodate delegates! #ASH22 #Myeloma @MyelomaUK
Bob Munro retweeted
Replying to @DrEmmaSearle
@DrEmmaSearle presenting exciting data from the TEC-2 study. TEC/Dara/Len combination. Impressive >=VGPR rate of 90% #ASH22 #mmsm
Bob Munro retweeted
Myeloma Clinical Olympics on the potential of new treatments (Bi- Specifics and T-cells) to deliver better outcomes for relapsed and refractory patients. #ASH22 @MyelomaUK


























